» Articles » PMID: 28741564

Surviving at a Distance: Organ-Specific Metastasis

Overview
Journal Trends Cancer
Publisher Cell Press
Specialty Oncology
Date 2017 Jul 26
PMID 28741564
Citations 268
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical manifestation of metastasis in a vital organ is the final stage of cancer progression and the main culprit of cancer-related mortality. Once established, metastasis is devastating, but only a small proportion of the cancer cells that leave a tumor succeed at infiltrating, surviving, and ultimately overtaking a distant organ. The bottlenecks that challenge cancer cells in newly invaded microenvironments are organ-specific and consequently demand distinct mechanisms for metastatic colonization. We review the metastatic traits that allow cancer cells to colonize distinct organ sites.

Citing Articles

Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma.

Delgado-Bellido D, Chacon-Barrado A, Olmedo-Pelayo J, Jordan Perez C, Gilabert-Prieto P, Diaz-Martin J Cell Death Differ. 2025; .

PMID: 40000790 DOI: 10.1038/s41418-025-01469-9.


Mechanical signatures in cancer metastasis.

Agrawal A, Javanmardi Y, Watson S, Serwinski B, Djordjevic B, Li W NPJ Biol Phys Mech. 2025; 2(1):3.

PMID: 39917412 PMC: 11794153. DOI: 10.1038/s44341-024-00007-x.


Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.

Zuo Q, Kang Y Adv Exp Med Biol. 2025; 1464():347-370.

PMID: 39821033 DOI: 10.1007/978-3-031-70875-6_17.


Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges.

Ye Y, Yu S, Guo T, Zhang S, Shen X, Han G Biomolecules. 2025; 14(12.

PMID: 39766230 PMC: 11673737. DOI: 10.3390/biom14121523.


The metastatic cascade through the lens of therapeutic inhibition.

Miranda I, Jahan N, Shevde L Cell Rep Med. 2024; 6(1):101872.

PMID: 39706193 PMC: 11866422. DOI: 10.1016/j.xcrm.2024.101872.


References
1.
Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

2.
Korpal M, Ell B, Buffa F, Ibrahim T, Blanco M, Celia-Terrassa T . Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011; 17(9):1101-8. PMC: 3169707. DOI: 10.1038/nm.2401. View

3.
Gao H, Chakraborty G, Lee-Lim A, Mo Q, Decker M, Vonica A . The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012; 150(4):764-79. PMC: 3711709. DOI: 10.1016/j.cell.2012.06.035. View

4.
Jones D, Nakashima T, Sanchez O, Kozieradzki I, Komarova S, Sarosi I . Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006; 440(7084):692-6. DOI: 10.1038/nature04524. View

5.
Gupta G, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K . ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A. 2007; 104(49):19506-11. PMC: 2148319. DOI: 10.1073/pnas.0709185104. View